Search results
The ultimate evergreen Christmas gift
‘Tis the season for goodwill so this year why not spend your cash on a present that will last for life and one that will benefit the planet and generations to come, by gifting a tree?
Cambs haulage company supports British Antarctic Survey’s net zero goals
Launched onto UK roads for the first time in October, The Welch Group’s 100% electric HGV supported the British Antarctic Survey (BAS) this week, providing them with a net zero transport solution.
Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives
- Funding to support further development of lead programme for a novel therapeutic targeting Gram-negative bacteria including Multi-Drug-Resistant strains
- Optimisation will also support application of the Alphamer® platform across other therapeutic indicat
Metrion Biosciences appoints Lee Patterson as CEO
- Significant CRO C-suite experience expected to drive growth and commercial expansion into global markets
Cambridge, UK, 25 November 2024: Metrion Biosciences, the specialist preclinical contract research organisation (CRO) and a leader in ion channe
Guardtech Group hoping to end golden year with more success at SME National Business Awards
Suffolk contamination control experts looking to add Best Enterprising Business prize to epic 2024 awards haul at glitzy Wembley Stadium showpiece on 6 December
CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients.
Analytics for clinical development strategy: Integrated optimization of an oncology program
Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC.
Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized.
Infertility - A public health concern
The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child.
CP Packaging takes space at The EpiCentre
CP Packaging, a leading UK custom printed packaging company for the food and beverage sector, has taken space at The EpiCentre.
Shining a light on the life sciences
The OBN Awards struck an optimistic tone as the best of the UK’s life sciences industry was celebrated
Medicilon delivers fast turnaround time to meet your FDA submission deadline for SEND Format Conversion
Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission.
Chris Dunn shortlisted as a Top UK Business Adviser
Chris Dunn has been shortlisted for the UK’s Top Business Advisers Awards. Chris who delivers consulting, coaching, and mentoring services to help entrepreneurs grow their business was picked from hundreds of advisers from around the UK for his outstanding work in business development.
Volunteer hospice drivers recognised by Hunts Forum 2024 Volunteer Awards
Volunteer drivers Edwin and Duncan receive Hunts Forum 2024 Volunteer Awards.
Large-area scanning for high-speed AFM: latest developments announced
Prior Scientific's Queensgate and NPL revealed their latest breakthrough at Euspen's Special Interest Conference: Precision Motion Systems and Control in November.
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
- Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae
- PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects
COPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care.
The EpiCentre is working with Microsoft to support innovative early-stage businesses
Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses.
CrestOptics and Tomocube partner to advance 3D imaging with new multimodal imaging platform
- First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection
- New system showcased at SPAOM24 (20th-22
Tagomics announces a multiomic profiling co-marketing agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line
Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System
Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics
First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing therapeutics for autoimmune diseases
About Redgate Software
Today, more than 200,000 people globally, including 92% of the Fortune 100, trust Redgate to deliver ingeniously simple software.
40% discount on Carbon Literacy and AI short courses at Cambridge Marketing College
Cambridge Marketing College have a range of November offers! Get a 40% discount on Carbon Literacy and AI short courses and a 15% discount on CIM qualifications or CIM modular awards.
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis
- Paper in the European Journal of Medicinal Chemistry discloses the optimisation process leading to the selection for development of ETD001, an inhaled ENaC blocker with a best-in-class profile
- ETD001 commenced Phase 2 clinical study in people with cystic fibrosis in Jul